KK
MIRM icon

KLP Kapitalforvaltning’s Mirum Pharmaceuticals MIRM Stock Holding History

KLP Kapitalforvaltning’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
9,600
+1,300
+16% +$131K ﹤0.01% 1065
2026
Q1 		$767K Buy
8,300
+300
+4% +$28.2K ﹤0.01% 1179
2025
Q4 		$632K Buy
8,000
+400
+5% +$28.7K ﹤0.01% 1290
2025
Q3 		$557K Hold
7,600
– – ﹤0.01% 1344
2025
Q2 		$387K Buy
7,600
+900
+13% +$40.1K ﹤0.01% 1480
2025
Q1 		$302K Hold
6,700
– – ﹤0.01% 1560
2024
Q4 		$277K Buy
+6,700
New +$279K ﹤0.01% 1687

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's MIRM Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Mirum Pharmaceuticals (MIRM) stake by 16% in Q2 2026, buying an estimated $131K and bringing the position to 9,600 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

KLP Kapitalforvaltning first reported a position in MIRM in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • KLP Kapitalforvaltning held 9,600 shares of Mirum Pharmaceuticals worth $1.12M as of Q2 2026.
  • KLP Kapitalforvaltning bought 1,300 Mirum Pharmaceuticals shares in Q2 2026, an estimated $131K.
  • Mirum Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1065 holding.
  • KLP Kapitalforvaltning first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.